ES Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

Executive Summary

Shaiful Azmi Yahaya

Jonathan Yap, Kentaro Hayashida, Michael Kang Yin Lee, Dion Stub,Jimmy Kim Fatt Hon, Kay Woon Ho, Sidney Lo, Ashok Seth, Hyo-Soo Kim, Nattawut Wongpraparut, Quang Ngoc Nguyen, Timothy C Dy, Mann Chandavimol, See Hooi Ewe, Wei-Hsian Yin, Yung-Tsai Lee, Edgar L Tay, Karl Poon, Mao Chen, Angus Chui, Simon Cheung-Chi Lam, Ravinder Singh Rao, Masaki Izumo, Rajesh Nair, Gilbert HL Tang, Minoru Tabata, Shaiful Azmi Yahaya, Kenny YK Sin, Duk-Woo Park, Jianan Wang and Jack Tan Wei Chieh

Published: Journal of Asian Pacific Society of Cardiology. 1 Nov 2024;3:e41

Background

The article discusses a heart condition called aortic stenosis, where the heart’s main valve narrows, making it harder for blood to flow properly. A modern treatment called Transcatheter Aortic Valve Implantation (TAVI) is becoming more popular in the Asia-Pacific region because it is less invasive than traditional open-heart surgery.

However, different countries in the region handle the condition differently due to differences in anatomy, healthcare resources, and medical opinions. To help guide doctors, a group of heart experts created recommendations on when and how to use TAVI.

Key Findings:

  • TAVI is a good option for older patients or those who are too high-risk for open-heart surgery

  • Doctors should consider a patient’s overall health, age, and condition severity when deciding between TAVI and surgery

  • Regular heart check-ups are needed to monitor patients with aortic stenosis, even if they don’t have symptoms.

  • Some patients without symptoms may still need treatment if tests show their condition is getting worse.

  • There are some risks with TAVI, including possible heart rhythm issues, bleeding, or stroke, but overall, it is a safe procedure when done by experienced doctors